Clinical Trials Directory

Trials / Unknown

UnknownNCT05677724

Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Fubing Wang · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In summary, with the help of single-cell sequencing technology, this study aims to focus on elucidating the influence of HBV-induced hepatocellular carcinoma cell metabolic changes on microenvironment remodeling. With the help of hepatocellular carcinoma microenvironment changes, this study provide a more accurate diagnosis and treatment method for HBV-induced hepatocellular carcinoma.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHBV DNA SequencingClinical surgical specimens were obtained, cleaned briefly and transported to the laboratory. Single-cell suspension preparation and blood cell separation were performed, single-cell sorting suspension was prepared and put on the machine, sorting and library construction were performed, and mRNA sequencing adaptor was docked. Single cell data analysis. Based on the findings of single cell analysis, functional verification tests of tumor immune microenvironment cell groups and functional changes of tumor cells were designed.

Timeline

Start date
2022-07-01
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2023-01-10
Last updated
2023-01-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05677724. Inclusion in this directory is not an endorsement.